4.2 Article

P38 Mitogen-Activated Protein Kinase Signal Transduction in the Diagnosis and Follow Up of Immunotherapy of Wasp Venom Allergy

Journal

CYTOMETRY PART B-CLINICAL CYTOMETRY
Volume 78B, Issue 5, Pages 302-307

Publisher

WILEY
DOI: 10.1002/cyto.b.20531

Keywords

basophils; CD63; immunotherapy; p38 mitogen-activated protein kinase; signal transduction; hymenoptera venom

Funding

  1. University of Antwerp (SBO) [2919]

Ask authors/readers for more resources

Background: P38 mitogen-activated protein kinase (MAPK) is known to govern IgE-mediated basophil activation. Intracellular phosphorylated p38 MAPK (Pp38 MAPK) in IgE-activated basophils can be quantified flow cytometrically. Objectives: To study whether Pp38 MAPK constitutes a potential novel read-out for flow-assisted diagnosis of hymenoptera venom allergy and to investigate whether this marker allows follow-up of successful venom immunotherapy (VIT). Methods: Fifty-two patients with documented wasp venom allergy and seven wasp-stung asymptomatic control individuals were enrolled. Wasp venom-induced basophil activation was analyzed flow cytometrically with anti-IgE, anti-CD63, and anti-Pp38 MAPK to assess their activation status before starting immunotherapy. To assess whether p38 MAPK constitutes a candidate marker for monitoring VIT, we repeated the basophil activation test (BAT) in 25 patients on the fifth day of a build-up immunotherapy. In addition, we investigated whether the Pp38 MAPK-based BAT could contribute in the decision of discontinuing VIT in a cross-sectional analysis in 13 patients receiving treatment for 3 years and 14 patients receiving treatment for 5 years. Results: Patients exhibited a dose-dependent basophil activation with phosphorylation of p38 MAPK and upregulation of downstream CD63. In contrast, stung controls demonstrated a dose-dependent but abrogated signal transduction in basophils with less and shorter duration of the phosphorylation of p38 MAPK and without subsequent upregulation of CD63. When repeated after 5 days of VIT and when investigated cross-sectionally after 3 years or 5 years of maintenance therapy, no effect of VIT on the phosphorylation of p38 MAPK was demonstrable. Conclusions: This study discloses that not only basophils from patients, but also from the stung control individuals, respond to wasp venom stimulation with phosphorylation of p38 MAPK, although to a lesser extend. No clear effect of VIT on the phosphorylation of p38 MAPK was shown. Thus, although p38 MAPK provides an additional tool in the diagnosis of wasp venom allergy, it does not contribute to the decision whether to stop successful VIT. (C) 2010 International Clinical Cytometry Society

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Allergy

Basophil activation test in the diagnosis of hypersensitivity reactions to quinolones by Loli-Ausejo et al

Didier G. Ebo, Athina L. Van Gasse, Jessy Elst, Christel Mertens, Vito Sabato

CLINICAL AND EXPERIMENTAL ALLERGY (2021)

Review Allergy

Principles, potential, and limitations of ex vivo basophil activation by flow cytometry in allergology: A narrative review

Didier G. Ebo, Chris H. Bridts, Christel H. Mertens, Vito Sabato

Summary: The major challenge in allergy diagnosis is the development of accessible and reliable diagnostics for predicting clinical outcomes after exposure to allergens. Flow-assisted analysis and the basophil activation test (BAT) show promise in meeting this requirement for various IgE-dependent allergies, but proper execution and interpretation are essential. Other uses of BAT include therapeutic monitoring and identifying allergenic recognition sites.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Review Allergy

Non-specific lipid-transfer proteins: Allergen structure and function, cross-reactivity, sensitization, and epidemiology

Isabel J. Skypala, Ricardo Asero, Domingo Barber, Lorenzo Cecchi, Arazeli Diaz Perales, Karin Hoffmann-Sommergruber, Elide A. Pastorello, Ines Swoboda, Joan Bartra, Didier G. Ebo, Margaretha A. Faber, Montserrat Fernandez-Rivas, Francesca Gomez, Anastasios. P. Konstantinopoulos, Olga Luengo, Ronald van Ree, Enrico Scala, Stephen J. Till

Summary: Non-specific lipid transfer proteins (nsLTP) are important proteins present in plant species, playing a key role in allergies and reactions to plant foods. Studies have shown that nsLTP have highly conserved structures and can cause allergic reactions to different plant-related foods and non-food sources.

CLINICAL AND TRANSLATIONAL ALLERGY (2021)

Letter Allergy

In search of the golden ratio for cannabis allergy: Utility of specific allergen-to-total IgE ratios

Ine I. Decuyper, Hans-Peter Rihs, Christel H. Mertens, Athina Ludovica Van Gasse, Jessy Elst, Margaretha A. Faber, Margo M. Hagendorens, Vito Sabato, Didier G. Ebo

ALLERGY (2021)

Letter Allergy

Tryptase release does not discriminate between IgE- and MRGPRX2-mediated activation in human mast cells

Jessy Elst, Marie-Line M. van Der Poorten, Athina L. Van Gasse, Christel Mertens, Margo M. Hagendorens, Didier G. Ebo, Vito Sabato

CLINICAL AND EXPERIMENTAL ALLERGY (2022)

Article Allergy

Mast cell activation test: A new asset in the investigation of the chlorhexidine cross-sensitization profile

Didier G. Ebo, Jessy Elst, Nele Moonen, Marie-Line M. van der Poorten, Athina L. Van Gasse, Lene H. Garvey, Chris H. Bridts, Christel Mertens, Margo M. Hagendorens, Vito Sabato

Summary: This study explored cross-reactivity between chlorhexidine (CHX) and structurally similar compounds using a passive mast cell activation test (pMAT). Results showed that some CHX-allergic patients exhibited mast cell degranulation responses to alexidine (ALX) and octenidine (OCT), while polyhexamethylene biguanide (PHMB) directly activated mast cells via occupation of MRGPRX2.

CLINICAL AND EXPERIMENTAL ALLERGY (2022)

Review Pharmacology & Pharmacy

Recent Knowledge and Insights on the Mechanisms of Immediate Hypersensitivity and Anaphylaxis: IgE/FcεRI- and Non-IgE/FcεRI-Dependent Anaphylaxis

Didier G. Ebo, Michiel Beyens, Kevin Heremans, Marie-Line M. van der Poorten, Athina L. Van Gasse, Christel Mertens, Michel Van Houdt, Vito Sabato, Jessy Elst

Summary: Immediate hypersensitivity reactions are challenging to diagnose due to their wide range of clinical presentations and uncertain mechanisms. These reactions can be caused by activation and degranulation of specific and nonspecific mast cells and basophils. Degranulation of these cells leads to the release of inflammatory mediators, which can vary depending on the trigger.

CURRENT PHARMACEUTICAL DESIGN (2023)

Review Medicine, General & Internal

Mastocytosis and related entities: a practical roadmap

Michiel Beyens, Jessy Elst, Marie-Line van der Poorten, Athina Van Gasse, Alessandro Toscano, Anke Verlinden, Katrien Vermeulen, Marie-Berthe Maes, J. N. G. Hanneke Oude Elberink, Didier Ebo, Vito Sabato

Summary: Mastocytosis is a complex multisystem disorder characterized by abnormal activation or accumulation of mast cells. The disease is often associated with mutations in the KIT gene and has varied clinical presentations. A new genetic trait related to mastocytosis has also been discovered recently.

ACTA CLINICA BELGICA (2023)

Letter Allergy

Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study

Jessy Elst, Marie-Line M. van der Poorten, Alessandro Toscano, Athina L. Van Gasse, Christel Mertens, Michiel Beyens, Margo M. Hagendorens, Didier G. Ebo, Vito Sabato

ALLERGY (2023)

Letter Allergy

Dual intracellular staining of CD154 (CD40L) and cytokines at single-cell level: A novel aid to document immediate hypersensitivity to amoxicillin

Didier G. Ebo, Jessy Elst, Christel Mertens, Marie-Line M. van der Poorten, Athina L. Van Gasse, Michel Van Houdt, Margo M. Hagendorens, Vito Sabato

CLINICAL AND EXPERIMENTAL ALLERGY (2023)

Article Medicine, General & Internal

Clinical practice of hereditary angioedema in Belgium: opportunities for optimized care

D. G. Ebo, M. M. van der Poorten, A. L. Van Gasse, R. Schrijvers, C. Hermans, M. Bartiaux, F. Haerynck, J. Willekens, H. Lapeere, M. Moutschen, O. Michel, V. Sabato

Summary: This paper assessed the alignment of Belgian clinical practice in hereditary angioedema (HAE) with the updated international guideline and identified opportunities for optimization. The main action points to further optimize the Belgian clinical practice of HAE include working towards total disease control, informing patients about new long-term prophylactic therapies, ensuring availability of on-demand therapy, implementing a more comprehensive assessment in daily clinical practice, and expanding the existing patient registry.

ACTA CLINICA BELGICA (2023)

Article Allergy

EAACI task force report: A consensus protocol for the basophil activation test for collaboration and external quality assurance

M. Pascal, S. M. Edelman, A. Nopp, C. Moebs, W. J. Geilenkeuser, E. F. Knol, D. G. Ebo, C. Mertens, M. H. Shamji, A. F. Santos, S. Patil, B. Eberlein, C. Mayorga, H. J. Hoffmann

ALLERGY (2023)

Editorial Material Anesthesiology

Suspected perioperative anaphylaxis: are we making the correct diagnosis?

Didier G. Ebo, Marie-Line M. van der Poorten, Philip M. Hopkins

Summary: We evaluate the diagnostic approach used in the Japanese Epidemiologic Study for Perioperative Anaphylaxis (JESPA) and caution against over-reliance on less sensitive and specific diagnostic tests in cases where clinical data indicate a likely immediate perioperative hypersensitivity reaction.

BRITISH JOURNAL OF ANAESTHESIA (2023)

Article Allergy

Exploring the thaumatin-like protein (TLP) as a candidate cannabis allergen in North-Western Europe

D. G. Ebo, H. P. Rihs, C. H. Mertens, A. L. Van Gasse, M. L. van Der Poorten, M. M. Hagendorens, V. Sabato, J. Elst

ALLERGY (2023)

No Data Available